{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:04:17Z","timestamp":1777053857059,"version":"3.51.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.2119\/molmed.2016.00096","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T07:43:09Z","timestamp":1476517389000},"page":"653-663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Stemness-Related Transcriptional Factors and Homing Gene Expression Profiles in Hepatic Differentiation and Cancer"],"prefix":"10.1186","volume":"22","author":[{"given":"Eman A","family":"Toraih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal S","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah I","family":"El-Falouji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham O","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader A","family":"Nemr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad H","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha M Abd","family":"El Fadeal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"key":"2201653_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4161\/cc.23200","volume":"12","author":"I Marzi","year":"2013","unstructured":"Marzi I, et al. (2013) The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming. Cell Cycle. 12:353\u201364.","journal-title":"Cell Cycle"},{"key":"2201653_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/73432","volume":"24","author":"DT Ross","year":"2000","unstructured":"Ross DT, et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24:227\u201335.","journal-title":"Nat. Genet."},{"key":"2201653_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.scr.2016.02.005","volume":"16","author":"M M\u00fcller","year":"2016","unstructured":"M\u00fcller M, et al. (2016) The role of pluripotency factors to drive stemness in gastrointestinal cancer. Stem Cell Res. 16:349\u201357.","journal-title":"Stem Cell Res."},{"key":"2201653_CR4","first-page":"483","volume":"32","author":"A Liu","year":"2013","unstructured":"Liu A, Yu X, Liu S. (2013) Pluripotency transcription factors and cancer stem cells: small genes make a big difference. Chin. J. Cancer 32:483\u20137.","journal-title":"Chin. J. Cancer"},{"key":"2201653_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1995-7645(14)60107-3","volume":"7","author":"X Zhao","year":"2014","unstructured":"Zhao X, et al. (2014) Expression level of pluripotent genes in incomplete reprogramming. Asian Pac. J. Trop. Med. 7:639\u201344.","journal-title":"Asian Pac. J. Trop. Med."},{"key":"2201653_CR6","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/cncr.21432","volume":"104","author":"UI Ezeh","year":"2005","unstructured":"Ezeh UI, Turek PJ, Reijo RA, Clark AT. (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer. 104:2255\u201365.","journal-title":"Cancer"},{"key":"2201653_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.18632\/oncotarget.2670","volume":"6","author":"S Ventel\u00e4","year":"2015","unstructured":"Ventel\u00e4 S, et al. (2015) CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance. Oncotarget. 6:144\u201358.","journal-title":"Oncotarget"},{"key":"2201653_CR8","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1158\/0008-5472.CAN-06-4608","volume":"67","author":"G Gu","year":"2007","unstructured":"Gu G, Yuan J, Wills M, Kasper S. (2007) Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 67:4807\u201315.","journal-title":"Cancer Res."},{"key":"2201653_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1440-1827.2010.02548.x","volume":"60","author":"B Furusato","year":"2010","unstructured":"Furusato B, Mohamed A, Uhl\u00e9n M, Rhim JS. (2010) CXCR4 and cancer. Pathol. Int. 60: 497\u2013505.","journal-title":"Pathol. Int."},{"key":"2201653_CR10","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP. (2010) CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin. Cancer Res. 16:2927\u201331.","journal-title":"Clin. Cancer Res."},{"key":"2201653_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/cvr\/cvs132","volume":"94","author":"C Cencioni","year":"2012","unstructured":"Cencioni C, Capogrossi MC, Napolitano M. (2012) The SDF-1\/CXCR4 axis in stem cell preconditioning. Cardiovasc. Res. 94:400\u20137.","journal-title":"Cardiovasc. Res."},{"key":"2201653_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/FJC.0b013e318093ec8f","volume":"50","author":"H Zheng","year":"2007","unstructured":"Zheng H, Fu G, Dai T, Huang H. (2007) Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha\/CXCR4 via PI3K\/Akt\/eNOS signal transduction pathway. J. Cardiovasc. Pharmacol. 50:274\u201380.","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2201653_CR13","volume-title":"Chemokine Receptors in Cancer, Cancer Drug Discovery and Development","author":"B Furusato","year":"2009","unstructured":"Furusato B, Rhim JS. (2009) CXCR4 and Cancer. In: Fulton AM, ed. Chemokine Receptors in Cancer, Cancer Drug Discovery and Development. New York: Humana Press."},{"key":"2201653_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/sj.bjc.6603251","volume":"95","author":"CC Schimanski","year":"2006","unstructured":"Schimanski CC, et al. (2006) Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br. J. Cancer 95:210\u201317.","journal-title":"Br. J. Cancer"},{"issue":"5","key":"2201653_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/cmi.2008.46","volume":"5","author":"H Liu","year":"2008","unstructured":"Liu H, et al. (2008). Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells. Cell Mol. Immunol. 5(5):373\u20138.","journal-title":"Cell Mol. Immunol."},{"key":"2201653_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/1471-2407-9-176","volume":"9","author":"Z Xiang","year":"2009","unstructured":"Xiang Z, et al. (2009) Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. BMC Cancer. 9:176.","journal-title":"BMC Cancer."},{"key":"2201653_CR17","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.2147\/DDDT.S86032","volume":"9","author":"F Hu","year":"2015","unstructured":"Hu F, et al. (2015) A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma. Drug Des. Deuel. Ther. 9:3625\u201333.","journal-title":"Drug Des. Deuel. Ther."},{"key":"2201653_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2008.04.050","volume":"267","author":"J Vandercappellen","year":"2008","unstructured":"Vandercappellen J, Van DJ, Struyf S. (2008) The role of CXC chemokines and their receptors in cancer. Cancer Lett. 267:226\u201344.","journal-title":"Cancer Lett."},{"key":"2201653_CR19","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1158\/0008-5472.CAN-06-2312","volume":"67","author":"V Gupta","year":"2007","unstructured":"Gupta V, et al. (2007) Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappa \u03b2 dependent and Smad1-dependent mechanism. Cancer Res. 67:2747\u201356.","journal-title":"Cancer Res."},{"key":"2201653_CR20","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1677\/erc.1.01301","volume":"14","author":"I Bieche","year":"2007","unstructured":"Bieche I, et al. (2007) chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr. Relat. Cancer. 14:1039\u201352.","journal-title":"Endocr. Relat. Cancer."},{"key":"2201653_CR21","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1158\/1078-0432.CCR-06-0736","volume":"12","author":"Y Wen","year":"2006","unstructured":"Wen Y, et al. (2006) GRO alpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin. Cancer Res. 12:5951\u20139.","journal-title":"Clin. Cancer Res."},{"key":"2201653_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00384-010-0901-1","volume":"25","author":"D Doll","year":"2010","unstructured":"Doll D, et al. (2010) Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival. Int. J. Colorectal. Dis. 25:573\u201381.","journal-title":"Int. J. Colorectal. Dis."},{"key":"2201653_CR23","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.3892\/ol.2016.4222","volume":"11","author":"G Wang","year":"2016","unstructured":"Wang G, et al. (2016) Overexpression of GRO-\u03b2 is associated with an unfavorable outcome in colorectal cancer. Oncology Letters. 11:2391\u20137.","journal-title":"Oncology Letters"},{"issue":"10","key":"2201653_CR24","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/liv.12209","volume":"33","author":"MK Shaker","year":"2013","unstructured":"Shaker MK, Abdella HM, Khalifa MO, El Dorry AK. (2013) Epidemiological characteristics of hepatocellular carcinoma in Egypt: a retrospective analysis of 1313 cases. Liver Int. 33(10):1601\u20136.","journal-title":"Liver Int."},{"key":"2201653_CR25","first-page":"e749587","volume":"2013","author":"CC Doan","year":"2013","unstructured":"Doan CC, et al. (2013) Differentiation of Human Umbilical Cord Lining Membrane-Derived Mesenchymal Stem Cells into Hepatocyte-Like Cells. ISRN Stem Cells. 2013:e749587.","journal-title":"Stem Cells"},{"key":"2201653_CR26","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.3748\/wjg.v12.i25.4014","volume":"12","author":"X-P Tang","year":"2006","unstructured":"Tang X-P, Zhang M, Yang X, Chen L-M, Zeng Y. (2006) Differentiation of human umbilical cord blood stem cells into hepatocytes in vivo and in vitro. World J. Gastroenterol. 12:4014\u201319.","journal-title":"World J. Gastroenterol."},{"key":"2201653_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/978-1-62703-128-8_20","volume-title":"Basic Cell Culture Protocols","author":"R Wagey","year":"2013","unstructured":"Wagey R, Short B. (2013) Isolation, Enumeration, and Expansion of Human Mesenchymal Stem Cells in Culture. In: Helgason CD, Miller CL, eds. Basic Cell Culture Protocols. New York; Humana Press: 315\u2013334."},{"key":"2201653_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/978-1-62703-128-8_29","volume-title":"Basic Cell Culture Protocols","author":"T Ishii","year":"2013","unstructured":"Ishii T, Yasuchika K, Ikai I. (2013) Hepatic Differentiation of Embryonic Stem Cells by Murine Fetal Liver Mesenchymal Cells. In: Helgason CD, Miller CL, eds. Basic Cell Culture Protocols. New York; Humana Press: 469\u201378."},{"key":"2201653_CR29","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1002\/lt.20034","volume":"10","author":"JM Llovet","year":"2004","unstructured":"Llovet JM, Fuster J, Bruix J. (2004) Barcelona Clinic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 10:S115\u201320.","journal-title":"Liver Transpl."},{"key":"2201653_CR30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40291-015-0143-6","volume":"19","author":"EA Toraih","year":"2015","unstructured":"Toraih EA, Mohammed EA, Farrag S, Ramsis N, Hosny S. (2015) Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients. Mol. Diagn. Ther. 19:179\u201390.","journal-title":"Mol. Diagn. Ther."},{"issue":"Suppl S1","key":"2201653_CR31","first-page":"11","volume":"4","author":"A Amin","year":"2015","unstructured":"Amin A, et al. (2015) Bioinformatics tools for detection of CXCR4 mutation and its relation to EGFR gene: Basic science and epidemiology. Clin. Cancer Investig. J. 4(Suppl S1):11\u201314.","journal-title":"Clin. Cancer Investig. J."},{"key":"2201653_CR32","unstructured":"McCune B, Mefford ML. (1999) PC-ORD. Multivariate Analysis of Ecological Data, Version 4. MJM Software Design."},{"key":"2201653_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF00039905","volume":"66","author":"DW Roberts","year":"1986","unstructured":"Roberts DW. (1986) Ordination on the basis of fuzzy set theory. Vegetatio. 66:123\u201331.","journal-title":"Vegetatio"},{"key":"2201653_CR34","doi-asserted-by":"publisher","first-page":"bau012","DOI":"10.1093\/database\/bau012","volume":"2014","author":"JX Binder","year":"2014","unstructured":"Binder JX, et al. (2014) COMPARTMENTS: unification and visualization of protein subcellular localization evidence. Database (Oxford). 2014:bau012.","journal-title":"Database (Oxford)"},{"key":"2201653_CR35","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, et al. (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38:W214\u201320.","journal-title":"Nucleic Acids Res."},{"key":"2201653_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K. (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer. 11:426\u201337.","journal-title":"Nat. Rev. Cancer."},{"key":"2201653_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/dvdy.20034","volume":"230","author":"AH Hart","year":"2004","unstructured":"Hart AH, et al. (2004) Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev. Dyn. 230:187\u201398.","journal-title":"Dev. Dyn."},{"key":"2201653_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ng.127","volume":"40","author":"I Ben-Porath","year":"2008","unstructured":"Ben-Porath I, et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40:499\u2013507.","journal-title":"Nat. Genet."},{"key":"2201653_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbrc.2009.02.156","volume":"383","author":"M Schoenhals","year":"2009","unstructured":"Schoenhals M, et al. (2009) Embryonic stem cell markers expression in cancers. Biochem. Biophys. Res. Commun. 383:157\u201362.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2201653_CR40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1365-2559.2011.03993.x","volume":"59","author":"Y Guo","year":"2011","unstructured":"Guo Y, et al. (2011) Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology. 59:763\u201375.","journal-title":"Histopathology"},{"key":"2201653_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jss.2010.11.903","volume":"174","author":"J Matsuoka","year":"2012","unstructured":"Matsuoka J, et al. (2012) Role of the Stemness Factors Sox2, Oct3\/4, and Nanog in Gastric Carcinoma. J. Surg. Res. 174:130\u20135.","journal-title":"J. Surg. Res."},{"key":"2201653_CR42","doi-asserted-by":"publisher","first-page":"e56324","DOI":"10.1371\/journal.pone.0056324","volume":"8","author":"W Luo","year":"2013","unstructured":"Luo W, et al. (2013) Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. PLoS One. 8:e56324.","journal-title":"PLoS One"},{"key":"2201653_CR43","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"M Clarke","year":"2006","unstructured":"Clarke M, et al. (2006) Cancer stem cells: perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66:9339\u201344.","journal-title":"Cancer Res."},{"key":"2201653_CR44","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3892\/mco.2015.639","volume":"3","author":"J Wang","year":"2015","unstructured":"Wang J, Zeng H, Li H, Zhang J, Wang S. (2015) Roles of sex-determining region Y-box 2 in cell pluripotency and tumor-related signaling pathways. Mol. Clin. Oncol. 3:1203\u20137.","journal-title":"Mol. Clin. Oncol."},{"key":"2201653_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1158\/0008-5472.CAN-09-1737","volume":"70","author":"J Mattison","year":"2010","unstructured":"Mattison J, et al. (2010) Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach. Cancer Res. 70:883\u201395.","journal-title":"Cancer Res."},{"key":"2201653_CR46","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/stem.29","volume":"27","author":"CR Jeter","year":"2009","unstructured":"Jeter CR, et al. (2009) Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells. 27:993\u20131005.","journal-title":"Stem Cells"},{"key":"2201653_CR47","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/PGP.0b013e3182055a1f","volume":"30","author":"X Zhou","year":"2011","unstructured":"Zhou X, et al. (2011) Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma. Int. J. Gynecol. Pathol. 30:262\u201370.","journal-title":"Int. J. Gynecol. Pathol."},{"key":"2201653_CR48","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s12032-011-9860-9","volume":"29","author":"T Lin","year":"2012","unstructured":"Lin T, Ding YQ, Li JM. (2012) Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma. Med. Oncol. 29:878\u201385.","journal-title":"Med. Oncol."},{"key":"2201653_CR49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4161\/cbt.9.4.10666","volume":"9","author":"HM Meng","year":"2010","unstructured":"Meng HM, et al. (2010) Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer. Cancer Biol. Ther. 9:295\u2013302.","journal-title":"Cancer Biol. Ther."},{"key":"2201653_CR50","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1245\/s10434-012-2314-6","volume":"19","author":"X Yin","year":"2012","unstructured":"Yin X, et al. (2012) Coexpression of stemness factors Oct4 and Nanog predict liver resection. Ann. Sur. Oncol. 19:2877\u201387.","journal-title":"Ann. Sur. Oncol."},{"key":"2201653_CR51","doi-asserted-by":"publisher","first-page":"e72435","DOI":"10.1371\/journal.pone.0072435","volume":"8","author":"XQ Wang","year":"2013","unstructured":"Wang XQ, et al. (2013) Epigenetic regulation of pluripotent genes mediates stem cell features in human hepatocellular carcinoma and cancer cell lines. PLoS One. 8:e72435.","journal-title":"PLoS One"},{"key":"2201653_CR52","doi-asserted-by":"publisher","first-page":"e8065","DOI":"10.1371\/journal.pone.0008065","volume":"4","author":"J Ji","year":"2009","unstructured":"Ji J, Werbowetski-Ogilvie TE, Zhong B, Hong S-H, Bhatia M. (2009) Pluripotent Transcription Factors Possess Distinct Roles in Normal versus Transformed Human Stem Cells. PLoS ONE. 4:e8065.","journal-title":"PLoS ONE."},{"key":"2201653_CR53","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/hep.25745","volume":"56","author":"J Shan","year":"2012","unstructured":"Shan J, et al. (2012) Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology. 56:1004\u201314.","journal-title":"Hepatology"},{"key":"2201653_CR54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12032-013-0503-1","volume":"30","author":"C Sun","year":"2013","unstructured":"Sun C, et al. (2013) Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug. Med. Oncol. 30:503.","journal-title":"Slug. Med. Oncol."},{"key":"2201653_CR55","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.febslet.2013.11.041","volume":"588","author":"JJ Zhou","year":"2014","unstructured":"Zhou JJ, et al. (2014) Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway. FEBS Lett. 588:566\u201373.","journal-title":"FEBS Lett."},{"key":"2201653_CR56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fphys.2015.00154","volume":"6","author":"I Karakasiliotis","year":"2015","unstructured":"Karakasiliotis I, Mavromara P. (2015) Hepatocellular carcinoma: from hepatocyte to liver cancer stem cell. Front. Physiol. 6:154.","journal-title":"Front. Physiol."},{"key":"2201653_CR57","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1158\/0008-5472.CAN-10-3320","volume":"71","author":"J Mathieu","year":"2011","unstructured":"Mathieu J, et al. (2011) HIF induces human embryonic stem cell markers in cancer cells. Cancer Res. 71:4640\u201352.","journal-title":"Cancer Res."},{"key":"2201653_CR58","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1038\/bcj.2014.82","volume":"4","author":"B Muz","year":"2014","unstructured":"Muz B, de la Puente P, Azab F, Luderer M, Azab AK. (2014) Hypoxia promotes stem cell-like phenotype in multiple myeloma cells. Blood Cancer J. 4:e262.","journal-title":"Blood Cancer J."},{"key":"2201653_CR59","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1128\/JVI.02534-12","volume":"87","author":"N Vassilaki","year":"2013","unstructured":"Vassilaki N, et al. (2013) Low oxygen tension enhances hepatitis C virus replication. J. Virol. 87:2935\u201348.","journal-title":"J. Virol."},{"key":"2201653_CR60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ng1760","volume":"38","author":"YH Loh","year":"2006","unstructured":"Loh YH, et al. (2006) The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38:431\u201340.","journal-title":"Nat. Genet."},{"key":"2201653_CR61","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1158\/1078-0432.CCR-07-4404","volume":"14","author":"SH Chiou","year":"2008","unstructured":"Chiou SH, et al. (2008) Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 14:4085\u201395.","journal-title":"Clin. Cancer Res."},{"key":"2201653_CR62","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.1158\/0008-5472.CAN-10-2638","volume":"70","author":"SH Chiou","year":"2010","unstructured":"Chiou SH, et al. (2010) Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 70:10433\u201344.","journal-title":"Cancer Res."},{"key":"2201653_CR63","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3892\/ol.2011.415","volume":"2","author":"H Yasuda","year":"2011","unstructured":"Yasuda H, et al. (2011) CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer. Oncol. Lett. 2:1065\u201371.","journal-title":"Oncol. Lett."},{"key":"2201653_CR64","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00432-012-1186-2","volume":"138","author":"A Borrull","year":"2012","unstructured":"Borrull A, et. Al. (2012) Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells. J. Cancer Res. Clin. Oncol. 138:1145\u201354.","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2201653_CR65","doi-asserted-by":"publisher","first-page":"e15366","DOI":"10.1371\/journal.pone.0015366","volume":"6","author":"MH McLean","year":"2011","unstructured":"McLean MH, et al. (2011) The inflammatory microenvironment in colorectal neoplasia. PLoS One. 6: e15366.","journal-title":"PLoS One"},{"key":"2201653_CR66","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2119\/molmed.2009.00165","volume":"16","author":"VR Mas","year":"2010","unstructured":"Mas VR, Fassnacht R, Archer KJ, Maluf D. (2010) Molecular Mechanisms Involved in the Interaction Effects of Alcohol and Hepatitis C Virus in Liver Cirrhosis. Mol. Med. 16:287\u201397.","journal-title":"Mol. Med."},{"key":"2201653_CR67","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3748\/wjg.v17.i21.2658","volume":"17","author":"QM Dong","year":"2011","unstructured":"Dong QM, et al. (2011) Clinical significance of serum expression of GRO\u03b2 in esophageal squamous cell carcinoma. World J. Gastroenterol. 17:2658\u201362.","journal-title":"World J. Gastroenterol."},{"key":"2201653_CR68","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5","volume":"73","author":"JD Owen","year":"1997","unstructured":"Owen JD, et al. (1997) Enhanced tumor forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity\/growth regulated cytokine beta and gamma proteins. Int. J. Cancer 73:94\u2013103.","journal-title":"Int. J. Cancer"},{"key":"2201653_CR69","doi-asserted-by":"publisher","first-page":"e51848","DOI":"10.1371\/journal.pone.0051848","volume":"7","author":"K Shang","year":"2012","unstructured":"Shang K, et al. (2012) Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice. PLoS One. 7: e51848.","journal-title":"PLoS One"},{"key":"2201653_CR70","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1158\/1541-7786.MCR-08-0472","volume":"7","author":"B Wang","year":"2009","unstructured":"Wang B, et al. (2009) A key role for early growth response-1 and nuclear factor kappa-B in mediating and maintaining GRO\/CXCR2 proliferative signaling in esophageal cancer. Mol. Cancer Res. 7:755\u201364.","journal-title":"Mol. Cancer Res."},{"key":"2201653_CR71","doi-asserted-by":"publisher","first-page":"8093","DOI":"10.1038\/sj.onc.1207097","volume":"22","author":"M Burger","year":"2003","unstructured":"Burger M, et al. (2003) Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22:8093\u2013101.","journal-title":"Oncogene"},{"key":"2201653_CR72","first-page":"3833","volume":"63","author":"IS Zeelenberg","year":"2003","unstructured":"Zeelenberg IS, Ruuls-Van Stalle L, Roos E. (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 63:3833\u20139.","journal-title":"Cancer Res."},{"key":"2201653_CR73","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/S0002-9440(10)63248-8","volume":"165","author":"P Mavier","year":"2004","unstructured":"Mavier P, et al. (2004) Expression of stromal cell-derived factor-1 and of its receptor CXCR4 in liver regeneration from oval cells in rat. Am. J. Pathol. 165:1969\u201377.","journal-title":"Am. J. Pathol."},{"key":"2201653_CR74","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cgh.2012.11.029","volume":"11","author":"E Lee","year":"2013","unstructured":"Lee E, Edward S, Singal AG, Lavieri MS, Volk M. (2013) Improving screening for hepatocellular carcinoma by incorporating data on levels of alpha-fetoprotein, over time. Clin. Gastroenterol. Hepatol.11:437\u201340.","journal-title":"Clin. Gastroenterol. Hepatol"},{"key":"2201653_CR75","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/ajg.2015.100","volume":"110","author":"TS Chang","year":"2015","unstructured":"Chang TS, et al. (2015) Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis. Am. J. Gastroenterol. 110:836\u201344.","journal-title":"Am. J. Gastroenterol."},{"key":"2201653_CR76","doi-asserted-by":"publisher","first-page":"e0156801","DOI":"10.1371\/journal.pone.0156801","volume":"11","author":"TG Bird","year":"2016","unstructured":"Bird TG, et al. (2016) Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection. PLoS One. 11:e0156801.","journal-title":"PLoS One"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2016.00096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2016.00096\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2016.00096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2016.00096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T12:17:59Z","timestamp":1657455479000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2016.00096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2201653"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2016.00096","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"25 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}